ArticleClinical and experimental nephrology2025
Potential involvement of abnormal splicing in severe WT1-related disorders.
Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Kidney transplantation outcomes in children with WT1-associated kidney disease: a single-center cohort study.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
introductionWT1-related disorders are associated with WT1 gene variants. Recent advances in genetic medicine have led to a better understanding of the genotype-phenotype correlation in WT1-related diseases, particularly missense variants in exons 8 or 9 that lead to a wide range of severities. Exonic variants can lead to splicing abnormalities in rare diseases. No reports have investigated exonic variants in WT1 that cause aberrant splicing. We examined whether exonic variants in WT1 exon 8 or 9 cause splicing abnormalities and affect disease severity.
methodsWe selected nine rare missense variants in exon 8 or 9 in WT1 outside the DNA binding domain and C2H2 sites from the Human Gene Variant Database Professional that unexpectedly present severe phenotypes. We conducted functional splicing assays using hybrid minigenes for the nine variants containing exon 8 and 9 and surrounding sequences. Minigene vectors were transfected into cultured cells, and mRNA was analyzed. In silico analysis was performed.
resultsSplicing assays revealed that one of the nine variants caused aberrant splicing, with exon 8 skipping. One previously reported case with this variant showed particularly severe phenotype, progressing to kidney failure within 3 months.
conclusionsOne WT1 variant in exon 8 or 9 disrupted the splice site, leading to aberrant splicing in vitro and potentially contributing to an unexpectedly severe phenotype for a missense variant outside the DNA binding domain and C2H2 sites. In vitro splicing assays may help clarify the genotype-phenotype correlation in WT1-related disorders, especially for variants outside canonical functional domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.